Latest news with #pulmonaryHypertension
Yahoo
24-05-2025
- Business
- Yahoo
FDA Approves Liquidia Corporation (LQDA)'s YUTREPIA Amid Patent Dispute
Liquidia Corporation (NASDAQ:LQDA) announced today that the U.S. Food and Drug Administration (FDA) has approved YUTREPIA (treprostinil) inhalation powder for adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). A healthcare professional working on a computer terminal with a patient in the background. YUTREPIA, enabled by Liquidia Corporation (NASDAQ:LQDA)'s proprietary PRINT technology, is the first and only prostacyclin dry-powder formulation designed for deep-lung delivery using a low-effort, portable inhalation device. The approval is based on results from the Phase 3 INSPIRE trial, which showed YUTREPIA to be safe and well-tolerated, offering a new treatment option for over 105,000 U.S. patients suffering from PAH and PH-ILD. Liquidia Corporation (NASDAQ:LQDA)'s commercial team is preparing to launch YUTREPIA, aiming to improve exercise ability and quality of life for patients. However, United Therapeutics Corporation has filed a patent infringement lawsuit and is seeking a court order to block YUTREPIA's commercial launch, with a decision on the injunction still pending. While we acknowledge the potential of LQDA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LQDA and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None.
BBC News
11-05-2025
- Health
- BBC News
Shepshed man, 81, 'elated' to complete epic charity drive
A grandfather who underwent life-saving lung surgery has said he felt "elated" after driving the length of the UK for charity. Dave Whittington, 81, spent more than 30 hours behind the wheel of his 57-year-old MGC as he headed south from John O'Groats, arriving at Land's End on Whittington, from Shepshed in Leicestershire, said he set himself the challenge as part of recovery after he was diagnosed with chronic thromboembolic pulmonary hypertension in 2020."I'm very relieved both me and the car made it in one piece," he said. Mr Whittington, who was accompanied by his wife Thelma, 79, said the enormity of the challenge dawned on him when he reached John O'Groats at the northern tip of Scotland."I've had some health problems, and the car has hardly left Leicestershire in the past 15 years," he said."I thought, 'What on earth have we put ourselves up to?'"But we got all the way down to Land's End in Cornwall, 865 miles in all, without a single problem. I felt elated." 'We're still speaking' Mr Whittington, who has 10 grandchildren, underwent life-saving pulmonary endarterectomy surgery at Royal Papworth Hospital in nine-hour operation involved his heart being stopped and all the blood being drained from his body while clots and scar material were removed from his said he hoped the drive, which involved stops at number of pulmonary hypertension hospital centres, would raise awareness of the has also raised more than £1,200 for Pulmonary Hypertension Association UK and Royal Papworth Hospital Whittington added: "I want to thank everyone who has supported me and my wife Thelma. "We spent a lot of time in the car together - and we're still speaking."
